152 related articles for article (PubMed ID: 37958477)
1. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer.
Wu CC; Fang CY; Yu BH; Chang CM; Hsu TW; Hung CL; Hung SK; Chiou WY; Tsai JH
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958477
[TBL] [Abstract][Full Text] [Related]
2. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
4. Risk of systemic autoimmune diseases in gastric disease patients with proton pump inhibitor use: a nationwide cohort study in Taiwan.
Chen HY; Lin JJ; Yang B; Lin MC
Clin Rheumatol; 2020 Sep; 39(9):2773-2780. PubMed ID: 32152918
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors use and risk of chronic kidney disease in diabetic patients.
Yang H; Juang SY; Liao KF
Diabetes Res Clin Pract; 2019 Jan; 147():67-75. PubMed ID: 30500543
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
8. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.
Lei WY; Wang JH; Yi CH; Liu TT; Hung JS; Wong MW; Bair MJ; Vaezi MF; Orr WC; Chen CL
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101397. PubMed ID: 32224118
[TBL] [Abstract][Full Text] [Related]
9. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
[TBL] [Abstract][Full Text] [Related]
11. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
12. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
14. The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy.
Liang CS; Bai YM; Hsu JW; Huang KL; Ko NY; Tsai CK; Yeh TC; Chu HT; Tsai SJ; Chen TJ; Chen MH
Seizure; 2021 Apr; 87():88-93. PubMed ID: 33735722
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.
Snir Y; Leibovitzh H; Leibovici-Weissman Y; Vilkin A; Cohen AD; Shochat T; Niv Y; Dotan I; Feldhamer I; Boltin D; Levi Z
United European Gastroenterol J; 2021 Apr; 9(3):343-353. PubMed ID: 32962566
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Lu IT; Yeh HZ; Chang CS; Kao CH
Dose Response; 2018; 16(4):1559325818803283. PubMed ID: 30288155
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
